Rare Disease Data Trust
Mark is an experienced executive uniquely qualified in healthcare information technology having 35 years of experience and education in both clinical and technology delivery. As CTO of RDDT, Mark’s work in Artificial Intelligence, advanced analytics, and technology creates a perfect opportunity for a company specializing in pattern recognition and model development in search of prospective rare disease patients. His focus for the last 10 years has been on the comprehensive collection and analysis of data for the development of groundbreaking product delivery in healthcare analytics, serving some of the largest healthcare enterprises in the country. Mark’s ability to deliver best practices and analyze and deliver emerging technology has led to solutions supporting current business trends in healthcare such as advanced healthcare analytics, regulatory reporting, population health, and disease management protocols with the latest in healthcare technology. Mark has served as CEO, CTO, CIO, and Director in his leadership roles at Hoffman LaRoche, Microsoft, Cerner, Symphony Performance Health, Press Ganey, and LifeWatch.
This person is not in any offices
Rare Disease Data Trust
Rare Disease Data Trust partners with community provider health systems to execute patient-centric data monetization, executing lost rare disease patient analytics, through commercially sponsored (by bio-pharma) targeted searches for undiagnosed rare disease patients. Accelerating the discovery and diagnosis of targeted rare disease patients and rescuing them from their diagnostic odysseys.